Although the mechanisms are currently unclear, ADSSL1 expression [65] and purine nucleotide metabolism [91] are also altered in cardiomyopathy and heart failure—ASA treatment could be therapeutically beneficial in these conditions. This evidence concerns the gene ADSS1 and cardiomyopathy.